A detailed history of Allspring Global Investments Holdings, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 390,619 shares of GKOS stock, worth $58.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
390,619
Previous 412,376 5.28%
Holding current value
$58.9 Million
Previous $48.8 Million 4.27%
% of portfolio
0.08%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$113.62 - $135.39 $2.47 Million - $2.95 Million
-21,757 Reduced 5.28%
390,619 $50.9 Million
Q2 2024

Jul 26, 2024

BUY
$89.48 - $118.35 $22 Million - $29.2 Million
246,322 Added 148.34%
412,376 $48.8 Million
Q1 2024

Apr 18, 2024

BUY
$76.4 - $96.33 $7.11 Million - $8.97 Million
93,076 Added 127.54%
166,054 $15.7 Million
Q4 2023

Jan 25, 2024

BUY
$59.53 - $85.11 $4.24 Million - $6.06 Million
71,151 Added 3894.42%
72,978 $5.8 Million
Q3 2023

Oct 27, 2023

BUY
$69.23 - $79.09 $126,483 - $144,497
1,827 New
1,827 $137,000
Q2 2023

Jul 18, 2023

BUY
$45.44 - $71.21 $15,676 - $24,567
345 Added 28.47%
1,557 $110,000
Q1 2023

Apr 13, 2023

SELL
$43.88 - $52.48 $30,847 - $36,893
-703 Reduced 36.71%
1,212 $60,000
Q4 2022

Jan 23, 2023

SELL
$40.82 - $57.75 $1,714 - $2,425
-42 Reduced 2.15%
1,915 $0
Q3 2022

Oct 26, 2022

BUY
$46.84 - $58.49 $3,466 - $4,328
74 Added 3.93%
1,957 $104,000
Q2 2022

Jul 25, 2022

SELL
$34.86 - $63.77 $334,900 - $612,638
-9,607 Reduced 83.61%
1,883 $85,000
Q1 2022

May 02, 2022

BUY
$44.33 - $57.82 $33,158 - $43,249
748 Added 6.96%
11,490 $664,000
Q4 2021

Jan 28, 2022

BUY
$40.27 - $56.99 $432,580 - $612,186
10,742 New
10,742 $477,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.